BIOMAT Database Logo BIOMAT Database Logo

In vivo distribution of cytotoxic lymphocytes specifically stimulated against autologous tumor cells in vitro. 1983

H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada

UI MeSH Term Description Entries
D007890 Leiomyosarcoma A sarcoma containing large spindle cells of smooth muscle. Although it rarely occurs in soft tissue, it is common in the viscera. It is the most common soft tissue sarcoma of the gastrointestinal tract and uterus. The median age of patients is 60 years. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1865) Leiomyosarcoma, Epithelioid,Leiomyosarcoma, Myxoid,Epithelioid Leiomyosarcoma,Epithelioid Leiomyosarcomas,Leiomyosarcomas,Leiomyosarcomas, Epithelioid,Leiomyosarcomas, Myxoid,Myxoid Leiomyosarcoma,Myxoid Leiomyosarcomas
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D013667 Technetium The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, and atomic number 43. All technetium isotopes are radioactive. Technetium 99m (m Technetium 99m,99m, Technetium
D014594 Uterine Neoplasms Tumors or cancer of the UTERUS. Cancer of Uterus,Uterine Cancer,Cancer of the Uterus,Neoplasms, Uterine,Neoplasms, Uterus,Uterus Cancer,Uterus Neoplasms,Cancer, Uterine,Cancer, Uterus,Cancers, Uterine,Cancers, Uterus,Neoplasm, Uterine,Neoplasm, Uterus,Uterine Cancers,Uterine Neoplasm,Uterus Cancers,Uterus Neoplasm

Related Publications

H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
Generation of cytotoxic lymphocytes in vitro against autologous human leukaemia cells.
August 1976, Nature,
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
Tumor immunity: tumor suppression in vivo initiated by soluble products of specifically stimulated lymphocytes.
May 1971, Science (New York, N.Y.),
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
In vitro and in vivo activation of CD4+ lymphocytes by autologous tumor cells.
July 1990, International journal of cancer,
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
In vivo effects of lymphocytes sensitized in vitro against tumor cells.
January 1976, Annals of the New York Academy of Sciences,
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
Enucleated cytotoxic T lymphocytes bind specifically to target cells in vitro.
May 1980, Transplantation,
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
Distribution of autologous tumor-specific cytotoxic T lymphocytes in human metastatic melanoma.
August 1992, International journal of cancer,
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
Cytotoxic activity of rheumatoid and normal lymphocytes against allogeneic and autologous synovial cells in vitro.
September 1976, The Journal of clinical investigation,
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
In vitro and in vivo cytotoxic effect of AntiGan against tumor cells.
March 2018, Experimental and therapeutic medicine,
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
[Cytotoxicity of lymphocytes sensitized by autologous tumor cells in vitro, against autologous lung cancer cell lines].
April 1990, Nihon Geka Gakkai zasshi,
H Kimura, and Y Yamaguchi, and T Yusa, and M Baba, and N Sato, and T Fujisawa, and H Ohwada
Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
January 1996, The Journal of experimental medicine,
Copied contents to your clipboard!